Good afternoon :)
Aarey Drugs and Pharmaceuticals Ltd

Aarey Drugs and Pharmaceuticals Ltd

AAREYDRUGS Share Price

NSE
₹67.023.80% (-2.65)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health Care
Pharmaceuticals
Smallcap

With a market cap of ₹197 cr, stock is ranked 2,503

High Risk

Stock is 4.21x as volatile as Nifty

AAREYDRUGS Stock Scorecard

Performance

Avg

Price return has been average, nothing exciting

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Avg

The stock is not in the overbought zone

Red flags

Avg

The stock has a moderate number of red flags

How to use scorecard? Learn more

Health Care
Pharmaceuticals
Smallcap

With a market cap of ₹197 cr, stock is ranked 2,503

High Risk

Stock is 4.21x as volatile as Nifty

AAREYDRUGS Performance & Key Metrics

AAREYDRUGS Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
57.761.43—
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
36.715.790.58%

AAREYDRUGS Analyst Ratings & Forecast

—
Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

AAREYDRUGS Company Profile

Aarey Drugs & Pharmaceuticals is engaged in active pharmaceutical ingredient (API)/Bulk Drugs manufacturing.

AAREYDRUGS Similar Stocks (Peers)

Compare with peers Compare with peers 

AAREYDRUGS Similar Stocks (Peers)

Compare with peers Compare with peers 
Sun Pharmaceutical Industries Ltd
SUNPHARMA
PE Ratio
38.47
38.47
1Y Return
10.56%
10.56%
Buy Reco %
94.29
94.29
Torrent Pharmaceuticals Ltd
TORNTPHARM
PE Ratio
77.37
77.37
1Y Return
47.65%
47.65%
Buy Reco %
81.48
81.48
Cipla Ltd
CIPLA
PE Ratio
20.71
20.71
1Y Return
3.97%
3.97%
Buy Reco %
54.84
54.84
Dr Reddy's Laboratories Ltd
DRREDDY
PE Ratio
19.06
19.06
1Y Return
15.61%
15.61%
Buy Reco %
48.39
48.39
Lupin Ltd
LUPIN
PE Ratio
32.19
32.19
1Y Return
18.34%
18.34%
Buy Reco %
72.22
72.22
Compare with Peers

AAREYDRUGS Forecast

AAREYDRUGS Forecasts

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

AAREYDRUGS

AAREYDRUGS

Income

Balance Sheet

Cash Flow

AAREYDRUGS Income Statement

AAREYDRUGS Income Statement

Loading...

Quartersep 2023dec 2023mar 2024jun 2024sep 2024dec 2024mar 2025jun 2025sep 2025dec 2025
Total Revenue58.6776.77215.49128.49105.16134.47115.64103.7684.95100.61
Operating & Other expensessubtract55.9873.77211.79125.73101.42131.59112.30100.5181.5297.94
Depreciation/Amortizationsubtract1.271.061.150.471.510.900.410.490.690.83
Interest & Other Itemssubtract0.410.470.400.960.490.581.301.041.260.92
Taxes & Other Itemssubtract-0.220.44-0.010.090.150.681.160.360.460.35
EPS0.480.400.770.440.570.260.170.480.360.20
See Costs

EPS in ₹. Other numbers in ₹ cr

AAREYDRUGS Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2025FY 2025

Annual report

PDF
FY 2024FY 2024

Annual report

PDF
FY 2023FY 2023

Annual report

PDF
FY 2022FY 2022

Annual report

PDF
FY 2021FY 2021

Annual report

PDF
FY 2020FY 2020

Annual report

PDF
FY 2019FY 2019

Annual report

PDF
FY 2018FY 2018

Annual report

PDF
FY 2017FY 2017

Annual report

PDF
 

AAREYDRUGS Stock Peers

AAREYDRUGS Past Performance & Peer Comparison

AAREYDRUGS Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Valuation

Technical

Forecast

ScreenerCompare valuation on Screener

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Aarey Drugs and Pharmaceuticals Ltd49.141.43—
Sun Pharmaceutical Industries Ltd38.475.800.91%
Torrent Pharmaceuticals Ltd77.3719.480.73%
Cipla Ltd20.713.491.18%

AAREYDRUGS Stock Price Comparison

Compare AAREYDRUGS with any stock or ETF
Compare AAREYDRUGS with any stock or ETF
AAREYDRUGS
Loading...

AAREYDRUGS Holdings

AAREYDRUGS Shareholdings

AAREYDRUGS Promoter Holdings Trend

AAREYDRUGS Promoter Holdings Trend

Decreased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has decreased by 5.74%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

AAREYDRUGS Institutional Holdings Trend

AAREYDRUGS Institutional Holdings Trend

Decreased Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has decreased by 1.57%

Increased Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has increased by 2.73%

Tickertape Separator

AAREYDRUGS Shareholding Pattern

AAREYDRUGS Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding39.06%0.00%0.00%3.86%57.09%

Mar 2025

Jun 2025

Sep 2025

Dec 2025

AAREYDRUGS Shareholding History

AAREYDRUGS Shareholding History

SepDec '24MarJunSepDec '252.75%2.34%2.34%1.97%1.13%3.86%

AAREYDRUGS Insider Trades & Bulk Stock Deals

AAREYDRUGS Insider Trades & Bulk Stock Deals

Loading...

smallcases containing AAREYDRUGS stock

smallcases containing AAREYDRUGS stock

Looks like this stock is not in any smallcase yet.

AAREYDRUGS Events

AAREYDRUGS Events

AAREYDRUGS Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

AAREYDRUGS has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

AAREYDRUGS Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

AAREYDRUGS has not given any dividends in last 5 years

AAREYDRUGS Upcoming Dividends

AAREYDRUGS Upcoming Dividends

No upcoming dividends are available

AAREYDRUGS Past Dividends

AAREYDRUGS Past Dividends

Cash Dividend

Ex DateEx DateDec 13, 2018

Interim
Interim | Div/Share: ₹0.10

Dividend/Share

₹0.10

Ex DateEx Date

Dec 13, 2018

AAREYDRUGS Stock News & Opinions

AAREYDRUGS Stock News & Opinions

Earnings
Aarey Drugs & Pharmaceuticals standalone net profit declines 20.83% in the December 2025 quarter

Net profit of Aarey Drugs & Pharmaceuticals declined 20.83% to Rs 0.57 crore in the quarter ended December 2025 as against Rs 0.72 crore during the previous quarter ended December 2024. Sales declined 27.92% to Rs 96.43 crore in the quarter ended December 2025 as against Rs 133.79 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales96.43133.79 -28 OPM %-1.571.64 - PBDT1.752.30 -24 PBT0.921.40 -34 NP0.570.72 -21 Powered by Capital Market - Live

2 weeks agoCapital Market - Live
Corporate
Aarey Drugs & Pharmaceuticals to discuss results

Aarey Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 11 February 2026.Powered by Capital Market - Live

3 weeks agoCapital Market - Live
Earnings
Aarey Drugs & Pharmaceuticals standalone net profit declines 36.25% in the September 2025 quarter

Net profit of Aarey Drugs & Pharmaceuticals declined 36.25% to Rs 1.02 crore in the quarter ended September 2025 as against Rs 1.60 crore during the previous quarter ended September 2024. Sales declined 19.95% to Rs 84.16 crore in the quarter ended September 2025 as against Rs 105.14 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales84.16105.14 -20 OPM %3.143.55 - PBDT2.173.26 -33 PBT1.481.75 -15 NP1.021.60 -36 Powered by Capital Market - Live

3 months agoCapital Market - Live
Corporate
Aarey Drugs & Pharmaceuticals to table results

Aarey Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 November 2025.Powered by Capital Market - Live

3 months agoCapital Market - Live
Corporate
Aarey Drugs & Pharmaceuticals to hold AGM

Aarey Drugs & Pharmaceuticals announced that the Annual General Meeting(AGM) of the company will be held on 29 September 2025.Powered by Capital Market - Live

5 months agoCapital Market - Live
Earnings
Aarey Drugs & Pharmaceuticals standalone net profit rises 10.48% in the June 2025 quarter

Net profit of Aarey Drugs & Pharmaceuticals rose 10.48% to Rs 1.37 crore in the quarter ended June 2025 as against Rs 1.24 crore during the previous quarter ended June 2024. Sales declined 19.46% to Rs 102.21 crore in the quarter ended June 2025 as against Rs 126.91 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales102.21126.91 -19 OPM %1.670.93 - PBDT2.221.80 23 PBT1.731.33 30 NP1.371.24 10 Powered by Capital Market - Live

6 months agoCapital Market - Live
Corporate
Aarey Drugs & Pharmaceuticals announces board meeting date

Aarey Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 August 2025.Powered by Capital Market - Live

6 months agoCapital Market - Live
Earnings
Aarey Drugs & Pharmaceuticals standalone net profit declines 78.14% in the March 2025 quarter

Net profit of Aarey Drugs & Pharmaceuticals declined 78.14% to Rs 0.47 crore in the quarter ended March 2025 as against Rs 2.15 crore during the previous quarter ended March 2024. Sales declined 48.61% to Rs 108.10 crore in the quarter ended March 2025 as against Rs 210.35 crore during the previous quarter ended March 2024. For the full year,net profit declined 14.10% to Rs 4.02 crore in the year ended March 2025 as against Rs 4.68 crore during the previous year ended March 2024. Sales rose 19.80% to Rs 473.94 crore in the year ended March 2025 as against Rs 395.62 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales108.10210.35 -49 473.94395.62 20 OPM %-4.49-0.69 -0.471.13 - PBDT0.213.29 -94 8.049.72 -17 PBT1.632.14 -24 6.105.34 14 NP0.472.15 -78 4.024.68 -14 Powered by Capital Market - Live

9 months agoCapital Market - Live
Corporate
Aarey Drugs & Pharmaceuticals to table results

Aarey Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 30 May 2025.Powered by Capital Market - Live

9 months agoCapital Market - Live
Earnings
Aarey Drugs & Pharmaceuticals standalone net profit declines 29.41% in the December 2024 quarter

Net profit of Aarey Drugs & Pharmaceuticals declined 29.41% to Rs 0.72 crore in the quarter ended December 2024 as against Rs 1.02 crore during the previous quarter ended December 2023. Sales rose 74.93% to Rs 133.79 crore in the quarter ended December 2024 as against Rs 76.48 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales133.7976.48 75 OPM %1.643.53 - PBDT2.302.52 -9 PBT1.401.46 -4 NP0.721.02 -29 Powered by Capital Market - Live

1 year agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. What is the share price of Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) today?

    The share price of AAREYDRUGS as on 4th March 2026 is ₹67.02. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) share?

    The past returns of Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) share are
    • Past 1 week: -18.45%
    • Past 1 month: 8.86%
    • Past 3 months: -14.45%
    • Past 6 months: 5.07%
    • Past 1 year: 88.96%
    • Past 3 years: 144.03%
    • Past 5 years: 60.72%

  3. What are the peers or stocks similar to Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS)?

    The peers or stocks similar to Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) include:

  4. What is the market cap of Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) is ₹197.54 Cr as of 4th March 2026.

  5. What is the 52 week high and low of Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) share?

    The 52-week high of Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) is ₹100 and the 52-week low is ₹31.35.

  6. What is the PE and PB ratio of Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) stock?

    The P/E (price-to-earnings) ratio of Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) is 49.14. The P/B (price-to-book) ratio is 1.43.

  7. Which sector does Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) belong to?

    Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) belongs to the Health Care sector & Pharmaceuticals sub-sector.

  8. How to buy Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) shares?

    You can directly buy Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) shares on Tickertape. Simply sign up, connect your demat account and place your order.